Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • LITE vs MRNA✓SelectedUSD · MRNALITE vs MRNA performance historyLatest closeAs of-8.48%11/16
Stock and ETF performance explorer

LITE vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+1,147.4%
MRNA return
+182.7%
Excess return
+964.7%
Maximum drawdown
-55.0%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-8.5%-3.6%-4.9%-8.3%
7D-8.4%-20.0%+11.6%-7.7%
30D-33.7%-1.3%-32.5%-33.6%
3M-41.0%+240.0%-281.0%-44.8%
6M-43.8%+339.0%-382.7%-51.0%
YTD+48.1%+630.0%-581.8%+12.6%
1Y+135.2%+769.1%-633.9%+72.4%
3Y+1,147.4%+181.2%+966.2%+901.7%
All+1,147.4%+182.7%+964.7%+901.7%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling